Changes in Beneficial Ownership · 4
HEPION PHARMACEUTICALS INC
HEPAOTCEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-10-23
- Issuer
- Hepion Pharmaceuticals, Inc.
- Issuer CIK
- 0001583771
- Trading symbol
- HEPA
Reporting owner 1
- Name
- Stetz Gary S.
- Reporting owner CIK
- 0001532793
- Relationship
- Director · Officer
- Officer title
- Chief Financial Officer
- Address
- C/O HEPION PHARMACEUTICALS, INC., 22 WEST ST., SUITE 1B, RED BANK,, NJ, 07701
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | 0.14 | 2026-10-23 | A · Form 4 | 1,530,000 | A | 0 | [F1] | 2036-10-23 | Common Stock | 1,530,000 | 2,875,500 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- 127,500 options vest in equal amounts monthly over 12 months from date of grant.↩ 1
Signature 1
- Signed
- /s/ Gary S. Stetz
- Date
- 2026-10-27
Company context
Current securities
Recent company filings
- SCHEDULE 13G/A - filed by RICKEL KENNETH regarding Hepion Pharmaceuticals, Inc.Oct 21, 2026
- S-8 filingOct 14, 2026
- Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 9, 2026
- Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearOct 2, 2026
- Changes in Registrant's Certifying AccountantSep 28, 2026